MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 141 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $1,209,423 | -68.4% | 5,227 | -66.9% | 0.00% | -100.0% |
Q1 2023 | $3,830,373 | -58.5% | 15,811 | -50.3% | 0.00% | -50.0% |
Q4 2022 | $9,238,657 | +488.1% | 31,830 | +31.7% | 0.00% | – |
Q3 2022 | $1,571,000 | -10.1% | 24,176 | -1.0% | 0.00% | – |
Q2 2022 | $1,748,000 | -98.0% | 24,419 | -97.3% | 0.00% | -100.0% |
Q1 2022 | $88,434,000 | -21.0% | 901,290 | -31.8% | 0.02% | -16.7% |
Q4 2021 | $111,925,000 | +37.8% | 1,320,795 | +29.7% | 0.02% | +28.6% |
Q3 2021 | $81,228,000 | -3.9% | 1,018,018 | +17.3% | 0.01% | 0.0% |
Q2 2021 | $84,529,000 | -11.5% | 867,766 | +6.2% | 0.01% | -17.6% |
Q1 2021 | $95,546,000 | -6.2% | 816,834 | -10.8% | 0.02% | -10.5% |
Q4 2020 | $101,819,000 | +8.6% | 915,892 | +15.9% | 0.02% | 0.0% |
Q3 2020 | $93,785,000 | -1.3% | 789,903 | -5.8% | 0.02% | -9.5% |
Q2 2020 | $95,015,000 | +62.9% | 838,981 | -4.0% | 0.02% | +40.0% |
Q1 2020 | $58,343,000 | -33.1% | 873,915 | -8.7% | 0.02% | -16.7% |
Q4 2019 | $87,205,000 | +20.1% | 957,146 | +13.7% | 0.02% | +12.5% |
Q3 2019 | $72,610,000 | +740.1% | 842,147 | +921.2% | 0.02% | +700.0% |
Q2 2019 | $8,643,000 | -1.2% | 82,464 | +18.1% | 0.00% | 0.0% |
Q1 2019 | $8,748,000 | +8.7% | 69,842 | -2.2% | 0.00% | 0.0% |
Q4 2018 | $8,050,000 | -9.7% | 71,418 | +71.6% | 0.00% | 0.0% |
Q3 2018 | $8,914,000 | +1134.6% | 41,631 | +1511.7% | 0.00% | – |
Q2 2018 | $722,000 | – | 2,583 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
University of Wisconsin Foundation | 73,487 | $17,003,422 | 28.29% |
Tao Capital Management LP | 130,529 | $30,202 | 27.63% |
Paulson & Co. | 1,105,741 | $255,846,353 | 23.09% |
AlpInvest Partners B.V. | 211,488 | $48,934,093 | 11.18% |
Bain Capital Life Sciences Investors, LLC | 324,619 | $75,110,344 | 7.20% |
Avoro Capital Advisors LLC | 1,888,888 | $437,050,905 | 6.04% |
Propel Bio Management, LLC | 30,032 | $6,948,804 | 5.76% |
Baker Brothers Advisors | 1,969,798 | $455,771,861 | 5.19% |
Rosalind Advisors, Inc. | 25,000 | $5,784,500 | 4.76% |
TCG Crossover Management, LLC | 179,917 | $41,629,195 | 4.62% |